Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Neuronal acetylcholine receptor subunit alpha-7 | ||
Ligand | BDBM397127 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | FlexStation-Ca2+ Influx Assay | ||
EC50 | 300±n/a nM | ||
Citation | Maeng, CY; Jang, YK; Cha, SB; Shin, HW; Joung, CM; Yi, EJ Pharmaceutical composition comprising pyridone derivatives US Patent US9987259 Publication Date 6/5/2018 | ||
More Info.: | Get all data from this article, Assay Method | ||
Neuronal acetylcholine receptor subunit alpha-7 | |||
Name: | Neuronal acetylcholine receptor subunit alpha-7 | ||
Synonyms: | ACHA7_HUMAN | CHRNA7 | Cholinergic, Nicotinic Alpha7 | NACHRA7 | Neuronal acetylcholine receptor protein alpha-7 subunit | Neuronal acetylcholine receptor subunit alpha-7 (nAChR-alpha 7) | Nicotinic acetylcholine receptor alpha-7 (alpha7 nAChR) | ||
Type: | n/a | ||
Mol. Mass.: | 56448.33 | ||
Organism: | Homo sapiens (Human) | ||
Description: | CHRNA7 (NACHRA7) | ||
Residue: | 502 | ||
Sequence: |
| ||
BDBM397127 | |||
n/a | |||
Name | BDBM397127 | ||
Synonyms: | N-(1-azabicyclo[2.2.2]octan-3-yl)-1-(5-tert-butyl-2-thiazolyl)-6-oxo-3-pyridinecarboxamide | US10456385, Example 20 | US9987259, Example 20 | ||
Type | Small organic molecule | ||
Emp. Form. | C20H26N4O2S | ||
Mol. Mass. | 386.511 | ||
SMILES | CC(C)(C)c1cnc(s1)-n1cc(ccc1=O)C(=O)NC1CN2CCC1CC2 |(-7.67,2.49,;-6.9,1.15,;-7.67,-.18,;-6.13,2.49,;-5.36,1.15,;-4.46,2.4,;-2.99,1.92,;-2.99,.38,;-4.46,-.09,;-1.66,-.39,;-.33,.38,;1.01,-.39,;1.01,-1.93,;-.33,-2.7,;-1.66,-1.93,;-2.99,-2.7,;2.34,.38,;2.34,1.92,;3.67,-.39,;5.01,.38,;5.01,1.93,;6.34,2.7,;7.67,1.93,;7.67,.38,;6.34,-.39,;7.06,.96,;5.57,1.36,)| | ||
Structure |